Agoraphobia/Agoraphobic anxiety Mental and Behavioural Disorders Agoraphobia/Agoraphobic anxiety
Conditions
Interventions
Adults that self-identified with agoraphobia were randomised to the two treatment arms. Block randomisation was applied to ensure equal numbers of participants in each group (ratio 1:1).
Group 1: Pa
Sponsors
University of Roehampton
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 or above 2. Identify themselves as suffering from agoraphobia 3. Willing and able to provide informed consent to participate
Exclusion criteria
Exclusion criteria: 1. Inability to give informed consent due to significant cognitive or intellectual impairment 2. No adequate understanding of English as a first language 3. Not having a mobile device than can run the application as designed 4. Any significant disease or disorder which, in the opinion of the Investigators, may either put the person at risk because of participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of agoraphobic and panic symptoms are measured using the Panic and Agoraphobia Scale at baseline, 6 and 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Degree of subjective distress experienced because of agoraphobia is measured by using a single item (“How much distress have you experienced because of agoraphobia in the past week?”), which is rated from 1 (“No distress”) to 5 (“Extreme distress”) at baseline, 6 and 12 weeks 2. Completion of the intervention is measured as 1 (completion of the tasks) or 0 (non-completion of the tasks) at 6 and 12 weeks 3. Engagement with the apps is measured using app usage data (i.e. total number of times that users engaged with the app) at 6 and 12 weeks | — |
Countries
United Kingdom
Outcome results
None listed